Page last updated: 2024-09-04

docetaxel anhydrous and Sublingual Gland Neoplasms

docetaxel anhydrous has been researched along with Sublingual Gland Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatayama, Y; Kakehata, S; Maruya, S; Matsubara, A; Nagahata, M; Namba, A; Shinkawa, H; Shirasaki, T; Takeda, I; Yokoyama, J1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Sublingual Gland Neoplasms

ArticleYear
Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel.
    International journal of clinical oncology, 2006, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Parotid Neoplasms; Radiotherapy, Adjuvant; Sublingual Gland Neoplasms; Taxoids; Treatment Outcome

2006
chemdatabank.com